Similarly, in a Chinese cohort of 306 patients treated with IL-17A inhibitors for psoriasis, 17 out of 220 initially IGRA-negative individuals became IGRA-positive, and one case of active tuberculosis was reported. The gene discussed is IL17A; the disease is tuberculosis.